Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 8/20 | 0.65 |
| ▸ | CTRB1 | P17538 | 3/20 | 0.64 |
| ▸ | ACE | P12821 | 5/20 | 0.63 |
| ▸ | CPA1 | P15085 | 5/20 | 0.63 |
| ▸ | ACE2 | Q9BYF1 | 5/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alanyl-Dl-Phenylalanine SCHEMBL27689824 | 1.00 | MME (0.65) | MMECTRB1ACECPA1ACE2 | |
| Alanyl-Dl-Phenylalanine SCHEMBL28142228 | 1.00 | MME (0.65) | MMECTRB1ACECPA1ACE2 | |
| Alanyl-Dl-Phenylalanine SCHEMBL28127119 | 1.00 | MME (0.65) | MMECTRB1ACECPA1ACE2 | |
| Alanyl-Dl-Phenylalanine SCHEMBL4238049 | 1.00 | MME (0.65) | MMECTRB1ACECPA1ACE2 | |
| Alanyl-Dl-Phenylalanine SCHEMBL893240 | 1.00 | MME (0.65) | MMECTRB1ACECPA1ACE2 | |
| Alanyl-Dl-Phenylalanine SCHEMBL893241 | 1.00 | MME (0.65) | MMECTRB1ACECPA1ACE2 | |
| Alanyl-Dl-Phenylalanine SCHEMBL28743188 | 1.00 | MME (0.65) | MMECTRB1ACECPA1ACE2 | |
| Alanyl-Dl-Phenylalanine SCHEMBL28142226 | 1.00 | MME (0.65) | MMECTRB1ACECPA1ACE2 | |
| SCHEMBL29702065 | 0.97 | MME (0.61) | MMECTRB1ACECPA1ACE2 | |
| SCHEMBL10646215 | 0.94 | MME (0.58) | MMECTRB1ACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106565822-A | Preparation method for chiral L-alanyl-phenylalanine | 湖北泓肽生物科技有限公司 | 2017-04-19 | — | — | CN | claimed |
| US-20150291659-A1 | SOLOMONAMIDE ANALOGUE COMPOUNDS, PHARMACEUTICALS CONTAINING SOLOMONAMIDE ANALOGUE COMPOUNDS, AND PROCESSES FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-10-15 | — | — | US | claimed |
| EP-2925771-A1 | A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES | Council of Scientific & Industrial Research (IN) | 2015-10-07 | — | — | EP | claimed |
| WO-2014083578-A1 | A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESERACH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) | 2014-06-05 | — | — | WO | claimed |
| US-20100130416-A1 | MODULATION OF ANGIOGENESIS BY A-BETA PEPTIDE FRAGMENTS | ARCHER PHARMACEUTICALS, INC. (US) | 2010-05-27 | — | — | US | claimed |
| US-6429220-B1 | COMPRISES AN ISOTHIAZOLONE COMPOUND AND AN AMINOCARBOXYLIC ACID | KURITA WATER INDUSTRIES LTD. (JP) | 2002-08-06 | — | — | US | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| CN-86105930-A | RECEPTOR ANTIBODY SANDWICH ASSAY | — | 1987-03-11 | — | — | CN | claimed |
| CN-85106820-A | The antibiotic solid phase receptor assay of vancomycin | — | 1987-02-11 | — | — | CN | claimed |
| CN-119866889-A | Method for producing fragrant style tobacco leaves | 福建中烟工业有限责任公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119735637-A | PHA polymerase immobilized connecting peptide and PHA polymerase immobilization method | 深圳瑞德林生物技术有限公司 | 2025-04-01 | — | — | CN | disclosed |
| US-20240399776-A1 | COLOR DEVELOPER, THERMAL RECORDING MATERIAL, AND THERMAL RECORDING LAYER COATING MATERIAL | SANKO CO., LTD. (JP) | 2024-12-05 | — | — | US | disclosed |
| EP-3690439-B1 | A NONINVASIVE METHOD FOR MEASURING METABOLITES FOR SKIN HEALTH | PROCTER & GAMBLE (US) | 2024-03-27 | — | — | EP | disclosed |
| EP-0127108-B1 | PROCESS FOR PREPARING POLYPEPTIDES | MERCK & CO. INC. (US) | 1986-12-30 | — | — | EP | disclosed |
| US-4510083-A | POTASSIUM, CESIUM OR RUBIDIUM CARBONATE BUFFER FOR COUPLING OF AMINO ACID N-CARBOXYANHYDRIDE WITH ANOTHER AMINO ACID OR PEPTIDE | MERCK & CO., INC. (US) | 1985-04-09 | — | — | US | disclosed |
| EP-0127108-A1 | Process for preparing polypeptides | MERCK & CO. INC. (US) | 1984-12-05 | — | — | EP | disclosed |
| US-4134901-A | MERCAPTO SUBSTITUTED THIOPHENE-ONES | LEVER BROTHERS COMPANY (US) | 1979-01-16 | — | — | US | disclosed |
| US-3978240-A | FLAVORING | LEVER BROTHERS COMPANY (US) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130416-A1 | MODULATION OF ANGIOGENESIS BY A-BETA PEPTIDE FRAGMENTS | VEGFA, APP, IAPP | MME 68/4885CTRB1 1673/4885ACE 596/4885 |
| US-20150291659-A1 | SOLOMONAMIDE ANALOGUE COMPOUNDS, PHARMACEUTICALS CONTAINING SOLOMONAMIDE ANALOGUE COMPOUNDS, AND PROCESSES FOR THE PREPARATION THEREOF | CNR2, SRM, CNR1 | MME 1788/4885CTRB1 1842/4885ACE 1098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.